Skip to main content
. 2011 Jan 27;117(14):3759–3769. doi: 10.1182/blood-2010-08-299917

Table 2.

Patient-derived LCLs used in the functional studies and their corresponding nontruncating FANCA mutations on one or both alleles

Patient ID Mutation 1
Mutation 2
DNA Protein DNA Protein
FA5 c. 4198C>T (Ex 42) p.R1800C T*
FA40 c.1475A>G (Ex 16) p.H492R c.1475A>G (Ex 16) p.H492R
FA56 c.3913C>T (Ex 39) p. L1305F T
FA58 c.821C>T (Ex 9) p. L274P T
FA75 c.3788_3790delTCT (Ex 38) p.F1263del c.2639G>A (Ex 28) p.R880Q
FA82 c.3788_3790delTCT (Ex 38) p.F1263del c.709 + 5G>T (Ex 7) p.D237G+238ins10 (AFMTRCGFLD)
FA88 c.709 + 5G>A (Ex 7) p.D237G+238ins10 (AFMTRCGFLD) T
FA91 c.2224C>A (Ex 25) p. Q742K T
FA155 c.3788_3790delTCT (Ex 38) p.F1263del T
FA170 c.3788_3790delTCT (Ex 38) p.F1263del T
FA328 c.2303T>C (Ex 26) p. L768P c.2303T>C (Ex 26) p. L768P
*

T indicates truncating mutation.